Dr. Immergluck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5200 Harry Hines Blvd
Dallas, TX 75235Phone+1 214-590-8000
Education & Training
University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 2021 - 2024- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2018 - 2021
University of Florida College of MedicineClass of 2018, MD
University of FloridaBS, Interdisciplinary Studies: Basic Biology and Medicine, Summa Cum Laude, 2011 - 2015
Certifications & Licensure
TX State Medical License 2024 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 30 citationsHepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis.Patrick Marquardt, Po Hong Liu, Joshua Immergluck, Jocelyn Olivares, Ana B. Arroyo
Hepatology Communications. 2021-09-01 - 35 citationsProstaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery.Jenna L Leclerc, Andrew S Lampert, Matthew A. Diller, Joshua B. Immergluck, Sylvain Doré
ASN Neuro. 2015-04-13
Journal Articles
- Hepatocellular Carcinoma Screening Process Failures in Patients with CirrhosisPatrick Marquardt, Po-Hong Liu, Joshua Immergluck, Jocelyn Olivares, Ana Arroyo, Nicole E. Rich, Neehar D. Parikh, Adam C. Yopp, Amit G. Singal, Hepatology Communications, 5/4/2021
Professional Memberships
- American College of PhysiciansMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
